About Careers MedBlog Contact us

Avigan, the Anti-Ebola Drug is Authorised by Guinea's Government

by Julia Samuel on February 10, 2015 at 2:30 PM
Font : A-A+

Avigan, the Anti-Ebola Drug is Authorised by Guinea's Government

Successful initial trials of the drug to treat Ebola has led to the authorisation of the drug by Guinea's government for wider use in treatment centres.

The number of people with Ebola in Guinea has doubled in the past week across the three worst affected West African states - Guinea, Liberia and Sierra Leone.


Guinea's anti-Ebola task force said about two dozen new cases of Ebola had been recorded in the last two weeks, taking the total number to 53 as of Friday. Officials are accessing villages where they had previously faced local resistance to their presence.

French and Guinean teams in southern Guinea have tested the experimental Japanese drug Avigan, or favipiravir developed by Toyama Chemical, a subsidiary of Japan's Fujifilm, since mid-December.

French President Francois Hollande's office said that the results had been positive and the drug appeared to accelerate the recovery process of patients.

"We have decided to broaden the use of this drug. It will only be available in the Ebola Treatment Units, not the hospitals," said Sakoba Keita, coordinator of Guinea's Ebola response.

Health officials have not provided any data for the results of the trials of the anti-Ebola drug. Favipiravir has been distributed to the town of Coyah after testing in Gueckedou and Nzerekore and talks are underway to start the treatment in the capital, Conakry.

"The Ebola situation is getting better but we are not cured," said Jean-François Delfraissy, a French Ebola expert working alongside Guinean authorities to contain the crisis.

Source: Medindia


Recommended Reading

Latest Tropical Disease News

Hope for Pregnant Women: New Malaria Study Offers Optimistic News
Pregnant women in Korogwe, Tanzania are found to have a high risk of contracting malaria, which is one of the deadliest diseases in sub-Saharan Africa.
Nasal Swab can Help Detect Early Warning of Emerging Viruses
Can nasal swab test save you from emerging diseases? Yes, simple nasal swab can offer early detection of new deadly viruses.
<i>Naegleria Fowleri</i> Infection: Deadly Brain-Eating Amoeba Kills a South Korean Man
Brain-eating amoeba (Naegleria fowleri) infection claims a South Korean man's life.
Infrared Light Beam to Detect Malaria
Harmless infrared light is used to detect malaria with the help of a computer algorithm processed by a smart phone.
Monkeypox Virus in Testes of Non-human Primate Survivors Detected
Monkeypox virus may be shed into semen during both acute and convalescent stages of the disease in crab-eating macaques.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Avigan, the Anti-Ebola Drug is Authorised by Guinea's Government Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests